Mesna is detoxifying agent. It reduces the harmful effects of certain metabolites (breakdown products) of the cancer chemotherapy medicine ifosfamide (Ifex).

Mesna is used to prevent bleeding in the bladder (hemorrhagic cystitis) during chemotherapy with ifosfamide (Ifex).

Mesnabelongs to Anti-Cancer Therapeutic Category.

Aarti Healthcare Division of Aarti Industries Limited manufactures Mesnawith an annual capacity of 7200Kgs.

Mesnais available in the following Specifications/Grades.

Specification EP/BP
EDMF (CTD) CEP 2009-127
USDMF 22664
COS R0-CEP 2009-127-REV 01


One of the principles that enables Aarti to offer our customers the utmost in supply reliability and to further consolidate our competitive position is our backward integration of all the key intermediates that go into manufacturing of APIs.

Bicalutamide Ifosfamide Cyclophosphamide
Mesna Mercaptopurine Azathioprine


Note :

  1. Intermediates of above APIs will be available.
  2. Products Under Patent will not be sold until patent expiration in buyer's country.
  3. Purchase of any Patented Product will be sole responsibility of the Buyer.